Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-017928
Filing Date
2021-03-04
Accepted
2021-03-04 17:36:41
Documents
2
Period of Report
2021-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1583
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4885
  Complete submission text file 0001209191-21-017928.txt   7934
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Issuer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 141 PORTLAND STREET FIFTH FLOOR CAMBRIDGE MA 02139
Business Address
Kahn Clare (Reporting) CIK: 0001849236 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 21715511